Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race

NCT03098836 is registered in ClinicalTrials.gov with Daniel George, MD as lead sponsor.

NCT NCT03098836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03098836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Apalutamide and Abiraterone Acetate iN ChemoTHerapy-Naïve mEn With mCRPC Stratified by Race
Lead sponsor
Daniel George, MD
Phase
Phase 2
Overall status
Completed
Start date
July 10, 2017
Completion date
July 9, 2024
Enrollment
93 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer